New science to change your approach to feline parasite control
During this program, you can expect to learn NEW science about feline parasite control with a focus on feline heartworm and its importance.
Newsroom
DIAGNOSING CANINE INFLUENZA
Because of increasing prevalence, rapid spread, and the potential for up to 20% of dogs to have a severe disease course, veterinarians should examine further any dogs showing clinical signs. A clinic can use multiple methods to test for both strains (CIV H3N8 and CIV H3N2). Each of these tests can help with different readings, […]
Urinary Shedding Challenge Study
Prevention of Leptospiremia and Leptospiruria Following Vaccination With a DaPPv + 4-way Leptospira Combination Vaccine Rhonda L. LaFleur, Jennifer C. Dant, Anna L. Tubbs, Huchappa Jayappa, David Sutton, Ian Tarpey Background: Leptospirosis, characterized by high fever, anorexia, vomiting, abdominal pain, diarrhea, myalgia, polyuria/polydipsia, jaundice, epistaxis, hematuria, and/or reproductive failure, continues to cause considerable morbidity among […]
Disease & Mortality Study
Prevention of Disease and Mortality in Vaccinated Dogs Following Experimental Challenge With Virulent Leptospira. R LaFleur, J Dant, T Wasmoen. Intervet / Schering Plough Animal Health, Elkhorn, NE. Canine Leptospirosis can vary from subclinical infection to illness that ranges from mild to severe, including death, depending on the susceptibility of the dog, virulence […]
COMPETITIVE COMPARISON
ONLY NOBIVAC® LYME OFFERS POWERFUL COMPARATIVE BENEFITS AND PROVEN SAFETY.
PREVENTS JOINT ABNORMALITIES
NOBIVAC® LYME IS SHOWN TO BE EFFECTIVE AGAINST SUBCLINICAL ARTHRITIS, IN ADDITION TO CLINICAL DISEASE5 Following vaccination with Nobivac Lyme: No Borrelia burgdorferi were found in the joint No joint inflammation, stiffness, or lameness were observed5 40% of control dogs developed chronic joint inflammation5 27% of control dogs developed joint stiffness or lameness5 Dogs exhibited no signs […]
THE ADVANCED VACCIPURE™ FILTRATION TECHNOLOGY
FILTRATION PROCESS LEADS TO IMPROVED VACCINES1 To promote an even higher level of vaccine quality, Merck Animal Health introduced the unique VacciPure filtration process for manufacturing Nobivac® Lepto4 and Nobivac® Canine 1-DAPPV+L4. A porous filtration membrane selectively removes extraneous proteins, salts, and solvents The outcome – fewer total proteins and a more purified final product
UNMATCHED PROTECTION
NOBIVAC® LEPTO4 IS THE CLEAR CHOICE WHEN COMPARED WITH OTHER 4-WAY LEPTOSPIROSIS VACCINES24-27